Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical phase I and II data presented on TMC-435 for hepatitis C

April 15, 2011

Acetone level in exhaled breath as a new biomarker of heart failure

April 15, 2011

Merck & Co. describes new inhibitors of MAP/microtubule affinity-regulating kinase 3

April 15, 2011

TAK-075 is a new, stable, orally active bone anabolic agent for osteoporosis

April 15, 2011

Levels of pentraxin-related protein PTX3 may predict unresponsiveness to IVIG in Kawasaki's disease

April 14, 2011

Pfizer's new HSP 90 inhibitor PF-4942847 shows promise in triple-negative breast cancer in vivo

April 14, 2011

First-in-human data reported on GDC-0973 alone and in combination with GDC-0941

April 14, 2011

Abbott presents new ROCK-2 inhibitor with high specificity and selectivity

April 14, 2011

Janssen Pharma's new analgesics JNJ-40413269 and JNJ-40534832 show promise in vivo

April 13, 2011

Snapshots: New data on boceprevir in hepatitis C presented at EASL meeting

April 13, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...